{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:32:07Z","timestamp":1792711927842,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.07.087","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T17:45:24Z","timestamp":1393350324000},"page":"1527-1535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines"],"prefix":"10.1016","volume":"32","author":[{"given":"Sami L.","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori M.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Bolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Broutet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.07.087_bib0005","series-title":"Reproductive Health Strategy to Accelerate Progress Towards the Attainment of International Development Goals and Targets","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0010","series-title":"Investing in Development: A Practical Plan to Achieve the Millennium Development Goals","author":"UN Millennium Project","year":"2005"},{"issue":"40","key":"10.1016\/j.vaccine.2013.07.087_bib0015","first-page":"405","article-title":"Hepatitis B vaccines: WHO position paper","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0020","series-title":"Prevention and Control of Viral Hepatitis Infection: Framework for Global Action","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0025","series-title":"Hepatitis B: Immunization surveillance, assessment, and monitoring","author":"World Health Organization","year":"2013"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2013.07.087_bib0030","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.087_bib0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.087_bib0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0045","series-title":"Global incidence and prevalence of selected curable sexually transmitted infections \u2013 2008","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0050","series-title":"Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis. Methods and results used by WHO to generate 2005 estimates","author":"World Health Organization","year":"2011"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.087_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.07.087_bib0060","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: a systematic review of the literature","volume":"194","author":"Dunne","year":"2006","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.087_bib0065","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jadohealth.2011.03.010","article-title":"Age-specific prevalence of human papillomavirus infection in males: a global review","volume":"48","author":"Smith","year":"2011","journal-title":"J Adolesc Health"},{"issue":"10","key":"10.1016\/j.vaccine.2013.07.087_bib0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2471\/BLT.07.046128","article-title":"An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection","volume":"86","author":"Looker","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.087_bib0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2013.07.087_bib0080","first-page":"456","article-title":"Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.087_bib0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAI.0b013e31815b2d9c","article-title":"Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial","volume":"46","author":"Watson-Jones","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"19","key":"10.1016\/j.vaccine.2013.07.087_bib0090","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.2012.3428","article-title":"Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review","volume":"307","author":"Chico","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0095","series-title":"HIV and sexually transmitted infections in the Western Pacific region, 2000\u20132010.","author":"World Health Organization Regional Office of the Western Pacific.","year":"2012"},{"issue":"12","key":"10.1016\/j.vaccine.2013.07.087_bib0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.olq.0000222703.12018.58","article-title":"China's syphilis epidemic: a systematic review of seroprevalence studies","volume":"33","author":"Lin","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.087_bib0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/sti.2007.029512","article-title":"Estimation of the impact of genital warts on health-related quality of life","volume":"84","author":"Woodhall","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0b013e3181632d61","article-title":"Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999\u20132004","volume":"35","author":"Dinh","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2013.07.087_bib0115","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0120","doi-asserted-by":"crossref","first-page":"e9973","DOI":"10.1371\/journal.pone.0009973","article-title":"Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers","volume":"5","author":"Aumakhan","year":"2010","journal-title":"PLoS One"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2013.07.087_bib0125","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.087_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/OLQ.0b013e3181f2e85f","article-title":"Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics","volume":"38","author":"Johnson","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.07.087_bib0135","doi-asserted-by":"crossref","first-page":"e1001292","DOI":"10.1371\/journal.pmed.1001292","article-title":"Neonatal mortality risk associated with preterm birth in East Africa, adjusted by weight for gestational age: individual participant level meta-analysis","volume":"9","author":"Marchant","year":"2012","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.087_bib0140","doi-asserted-by":"crossref","first-page":"e1001396","DOI":"10.1371\/journal.pmed.1001396","article-title":"Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data","volume":"10","author":"Newman","year":"2013","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.087_bib0145","first-page":"262","article-title":"Is Crede's prophylaxis for ophthalmia neonatorum still valid?","volume":"79","author":"Schaller","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"24","key":"10.1016\/j.vaccine.2013.07.087_bib0150","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1001\/jama.1986.03370240044034","article-title":"Prospective study of perinatal transmission of Chlamydia trachomatis","volume":"255","author":"Schachter","year":"1986","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.087_bib0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.087_bib0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/OLQ.0b013e318162c4c6","article-title":"Assessing neonatal herpes reporting in the United States, 2000\u20132005","volume":"35","author":"Dinh","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0165","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","article-title":"Risks of chronicity following acute hepatitis B virus infection: a review","volume":"20","author":"Hyams","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0175","series-title":"International Agency for Research on Cancer. Cervical cancer incidence and mortality worldwide","author":"GLOBOCAN.","year":"2008"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.087_bib0180","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0185","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0190","doi-asserted-by":"crossref","first-page":"c1642","DOI":"10.1136\/bmj.c1642","article-title":"Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial","volume":"340","author":"Oakeshott","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westrom","year":"1992","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.087_bib0200","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0002-9378(11)90790-X","article-title":"Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility","volume":"168","author":"Hillis","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.07.087_bib0205","doi-asserted-by":"crossref","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","article-title":"National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys","volume":"9","author":"Mascarhenas","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0210","series-title":"Infecundity, infertility, and childlessness in developing countries. DHS Comparative Reports No. 9","author":"Rutstein","year":"2004"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0215","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2005.10.028","article-title":"Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting","volume":"85","author":"Feinberg","year":"2006","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.087_bib0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fertnstert.2008.09.046","article-title":"A public health focus on infertility prevention, detection, and management","volume":"93","author":"Macaluso","year":"2010","journal-title":"Fertil Steril"},{"issue":"8455","key":"10.1016\/j.vaccine.2013.07.087_bib0225","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0140-6736(85)90594-X","article-title":"Worldwide patterns of infertility: is Africa different","volume":"2","author":"Cates","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.087_bib0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.087_bib0235","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa0904849","article-title":"Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2","volume":"362","author":"Celum","year":"2010","journal-title":"N Engl J Med"},{"issue":"9263","key":"10.1016\/j.vaccine.2013.07.087_bib0240","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(00)04331-2","article-title":"Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda","volume":"357","author":"Gray","year":"2001","journal-title":"Lancet"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2013.07.087_bib0245","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.aids.0000390704.35642.47","article-title":"Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning","volume":"24","author":"Hayes","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.087_bib0250","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.olq.0000154504.54686.d1","article-title":"Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection","volume":"32","author":"Sexton","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"9069","key":"10.1016\/j.vaccine.2013.07.087_bib0255","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(97)02190-9","article-title":"Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2013.07.087_bib0260","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/OLQ.0b013e3181812d15","article-title":"The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis","volume":"35","author":"Johnson","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2013.07.087_bib0265","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/QAD.0b013e328358d908","article-title":"Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis","volume":"26","author":"Houlihan","year":"2012","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.087_bib0270","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2105\/AJPH.92.3.378","article-title":"Relationships of stigma and shame to gonorrhea and HIV screening","volume":"92","author":"Fortenberry","year":"2002","journal-title":"Am J Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2013.07.087_bib0275","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/OLQ.0b013e31822b0bed","article-title":"A prospective study of the psychosocial impact of a positive Chlamydia trachomatis laboratory test","volume":"38","author":"Gottlieb","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0280","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2458-10-113","article-title":"The quality of life of patients with genital warts: a qualitative study","volume":"10","author":"Mortensen","year":"2010","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.087_bib0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1258\/ijsa.2011.010425","article-title":"Intimate partner violence and partner notification of sexually transmitted infections among adolescent and young adult family planning clinic patients","volume":"22","author":"Decker","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"9859","key":"10.1016\/j.vaccine.2013.07.087_bib0290","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0295","article-title":"The theoretical impact of vaccines that protect against sexually transmitted infections and disease","author":"Garnett","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.087_bib0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","article-title":"The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008","volume":"40","author":"Owusu-Edusei","year":"2013","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0305","series-title":"Global strategy for the prevention and control of sexually transmitted infections: 2006\u20132015: breaking the chain of transmission.","author":"World Health Organization","year":"2007"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0310","doi-asserted-by":"crossref","first-page":"ii10","DOI":"10.1136\/sextrans-2011-050178","article-title":"HIV\/sexually transmitted infection epidemiology, management and control in the IUSTI Africa region: focus on sub-Saharan Africa","volume":"87","author":"Lewis","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"21","key":"10.1016\/j.vaccine.2013.07.087_bib0315","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","article-title":"Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection","volume":"334","author":"Scholes","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0320","series-title":"The global elimination of congenital syphilis: rationale and strategy for action","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0325","series-title":"Sexually transmitted diseases treatment guidelines","author":"Centers for Disease Control and Prevention","year":"2010"},{"issue":"9551","key":"10.1016\/j.vaccine.2013.07.087_bib0330","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(06)69482-8","article-title":"Global control of sexually transmitted infections","volume":"368","author":"Low","year":"2006","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.07.087_bib0335","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/425275","article-title":"Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked","volume":"191","author":"Manhart","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.087_bib0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/epirev\/mxq010","article-title":"Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future","volume":"32","author":"Wetmore","year":"2010","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0345","series-title":"Sexually transmitted disease surveillance 2011","author":"Centers for Disease Control and Prevention","year":"2012"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0350","series-title":"Sexually transmitted infections in Europe 1990\u20132010. Stockholm: ECDC","author":"European Centre for Disease Prevention and Control","year":"2012"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0355","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/QAI.0b013e3181dc5dad","article-title":"HIV transmission rates in Thailand: evidence of HIV prevention and transmission decline","volume":"54","author":"Park","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0360","doi-asserted-by":"crossref","first-page":"ii31","DOI":"10.1136\/sextrans-2011-050181","article-title":"Utility and delivery of behavioural interventions to prevent sexually transmitted infections","volume":"87","author":"Aral","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.087_bib0365","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00007435-200008000-00002","article-title":"How effective is syndromic management of STDs? a review of current studies","volume":"27","author":"Pettifor","year":"2000","journal-title":"Sex Transm Dis"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2013.07.087_bib0370","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0375","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/652402","article-title":"Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies","volume":"201","author":"Geisler","year":"2010","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2013.07.087_bib0380","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/jama.2011.420","article-title":"Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection","volume":"305","author":"Tronstein","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.087_bib0385","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.087_bib0390","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2012.205107","article-title":"Cephalosporin-resistant gonorrhea in North America","volume":"309","author":"Kirkcaldy","year":"2013","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0395","first-page":"ii39","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance","volume":"87","author":"Lewis","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.07.087_bib0400","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cir705","article-title":"Trichomonas vaginalis genital infections: progress and challenges","volume":"53","author":"Bachmann","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.087_bib0405","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3201\/eid1806.111590","article-title":"Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009\u20132010","volume":"18","author":"Kirkcaldy","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2013.07.087_bib0410","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cid\/cis1022","article-title":"Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial","volume":"56","author":"Manhart","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0415","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/652400","article-title":"Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies","volume":"201","author":"Batteiger","year":"2010","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.07.087_bib0420","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/infdis\/jit094","article-title":"Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection","volume":"207","author":"Geisler","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.087_bib0425","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/sextrans-2012-050472","article-title":"High rates of reinfection and incidence of bacterial sexually transmitted infections in a cohort of female sex workers from two Indian cities: need for different STI control strategies?","volume":"89","author":"Das","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2013.07.087_bib0430","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature","volume":"36","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0435","first-page":"ii28","article-title":"Applying new technologies for diagnosing sexually transmitted infections in resource-poor settings","volume":"87","author":"Peeling","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.087_bib0440","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/OLQ.0b013e31823e2ff7","article-title":"Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999\u20132008","volume":"39","author":"Datta","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.087_bib0445","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amepre.2010.05.011","article-title":"Uptake of regular chlamydia testing by U.S. women: a longitudinal study","volume":"39","author":"Heijne","year":"2010","journal-title":"Am J Prev Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.07.087_bib0450","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1136\/sti.2006.023549","article-title":"Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics","volume":"83","author":"Freeman","year":"2007","journal-title":"Sex Transm Infect"},{"issue":"9630","key":"10.1016\/j.vaccine.2013.07.087_bib0455","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(08)60920-4","article-title":"Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Celum","year":"2008","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.07.087_bib0460","first-page":"170A","article-title":"Prevention of herpes simplex virus type 2 transmission with antiviral therapy","volume":"11","author":"Corey","year":"2004","journal-title":"Herpes"},{"issue":"13","key":"10.1016\/j.vaccine.2013.07.087_bib0465","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa0802556","article-title":"Male circumcision for the prevention of HSV-2 and HPV infections and syphilis","volume":"360","author":"Tobian","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0470","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/IJWH.S27601","article-title":"Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females","volume":"4","author":"Tan","year":"2012","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0475","series-title":"VOICE Study Team. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir\/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003)","author":"Marrazzo","year":"2013"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.087_bib0480","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.vaccine.2008.11.074","article-title":"Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa","volume":"27","author":"Freeman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0485","article-title":"Current status and prospects for development of an HSV-2 vaccine","author":"Johnston","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.087_bib0490","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/eurpub\/ckr046","article-title":"Chlamydia control activities in Europe: cross-sectional survey","volume":"22","author":"Low","year":"2012","journal-title":"Eur J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.087_bib0495","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/OLQ.0b013e31827bd637","article-title":"Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials","volume":"40","author":"Gottlieb","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.087_bib0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/OLQ.0b013e31815e41a3","article-title":"The arrested immunity hypothesis and the epidemiology of chlamydia control","volume":"35","author":"Brunham","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.07.087_bib0505","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1086\/652401","article-title":"Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control","volume":"201","author":"Gottlieb","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0510","article-title":"Development status and future vaccines for Chlamydia trachomatis infections","author":"Hafner","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0515","article-title":"Vaccines against gonorrhea: current status and future challenges","author":"Jerse","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0520","article-title":"Current status and prospects for development of a vaccine against Trichomonas infections","author":"Smith","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2013.07.087_bib0525","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1473-3099(11)70104-9","article-title":"Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis","volume":"11","author":"Hawkes","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0530","article-title":"Current status of syphilis vaccine development: need, challenges, prospects","author":"Cameron","year":"2013","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2013.07.087_bib0535","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0968-8080(08)32409-4","article-title":"Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications","volume":"16","author":"Goldie","year":"2008","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.vaccine.2013.07.087_bib0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jadohealth.2013.02.022","article-title":"Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs","author":"Broutet","year":"2013","journal-title":"J Adolesc Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13013984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13013984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:42:34Z","timestamp":1716565354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13013984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":108,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13013984"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}